About Enhancer

Enhancer ID: E_02_0940
Species: human
Position : chr11:69468761-69470761
Biosample name:
Experiment class : Low+High throughput
Enhancer type: Enhancer
Disease: --
Pubmed ID:  23108396
Enhancer experiment: 3C,ChIP,qPCR
Enhancer experiment description: ChIP confirmed that H2A.Z siRNA treatment lead to markedly reduced binding of H2A.Z to the CCND1 TSS. Concomitant to increased mRNA levels, polymerase II (pol II) recruitment to the CCND1 TSS slightly increased.

About Target gene

Target gene : CCND1(BCL1,D11S287E,PRAD1,U21B31)
Strong evidence: 3C
Less strong evidence: qPCR
Target gene experiment description: We conclude that enh2 has an active role in ER-independent CCND1 activation.To investigate whether the CCND1 TSS interacts with enh2, we used a chromatin conformation capture (3C) assay,which detects physical proximity between distal DNA sites by ligation of cross-linked restricted DNA fragments.

About TF

TF name : --
TF experiment: --
TF experiment description: --

About Function

Enhancer function : The enh2 has an active role in ER-independent CCND1 activation.
Enhancer function experiment: ChIP
Enhancer function
experiment description:
In addition, CCND1 activation in siH2AZ-transfected MDA-MB231 cells was accompanied by a strong recruitment of pol II to enh2 (Figure 1c, right panel), as described previously for E2 stimulated MCF-7 cells. We conclude that enh2 has an active role in ER-independent CCND1 activation.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs